Global X S&P 500 U.S. Revenue Leaders ETF

EGLE · ETF

$32.26−$0.1634 (−0.50%)TodayMarket closed ·
Prev close $32.43

About EGLE

EGLE was created on 2025-04-15 by Global X. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 2.28m in AUM and 372 holdings. EGLE tracks and index of US companies within the S&P 500, focusing on those generating over 50% of their revenue domestically, using a modified market-cap weighted structure with sector alignment to the S&P 500.

Issuer
Global X
Tracks
S&P 500 U.S. Revenue Leaders Index - Benchmark TR Gross
Expense ratio
0.19%
Assets under management
$2.28M
Inception
Apr 15, 2025
Asset class
Equity

EGLE key statistics

Price-earnings ratio
0.00
Dividend yield
2.42%
Average volume
154
Volume
7
Open price
$32.26
High today
$32.26
Low today
$32.26
52 Week high
$32.62
52 Week low
$27.00

Global X S&P 500 U.S. Revenue Leaders ETF (EGLE) at a glance

Global X S&P 500 U.S. Revenue Leaders ETF (EGLE) last traded at $32.26, with a price-to-earnings ratio of 0.00 and a dividend yield of 2.42%.

Volume so far is 7 shares, below the average of 154 shares a day.

Over the past year Global X S&P 500 U.S. Revenue Leaders ETF has ranged from $27.00 to $32.62, and now sits 94% of the way up that range.

EGLE news

  • Chandrima Sanyal

    Global X Doubles Down On Domestic Strength With New ETF Pair

  • Press releasePRNewswire

    Pangaea Logistics Solutions and M.T. Maritime Management Announce Agreement to Combine Fleets of Dry Bulk Vessels in All-Stock Transaction

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.